TAG ARCHIVES FOR research ethics roundup

22
Mar2013

Spring is finally here, and with it comes a new edition of the Research Ethics Roundup! Before you head out to the garden this weekend, take a moment to review these articles from the world of research ethics. From an appeal for stricter reporting standards worldwide, to a discussion of oversight in participant-led research, this bouquet of recent headlines is sure to brighten up your day!

Read more

8
Mar2013

On this day in 1817, the New York Stock exchange was founded. In recognition of this historic milestone, this week’s installment features articles on various aspects of the research industry, from relationships with corporate financiers, to maintaining positive public opinion. With so much to learn, we hope that you will invest some time in this week’s Research Ethics Roundup!


Herbalife cozies up [...] Read more

22
Feb2013

Though there’s still snow on the ground across much of the country, baseball fans celebrated the start of Spring Training this week, signaling that warm weather is just around the corner. If you’re looking to get “ahead in the count” of your professional development, take a crack at this week’s Research Ethics Roundup.

Ethics of 2 U.S.-funded cancer studies in India questioned: Two separate U.S.-funded studies of cervical cancer in India are the subject of growing controversy. Researchers conducting the study neglected to screen members of the control group for cervical cancer and failed to obtain adequate informed consent [...] Read more

8
Feb2013

Punxsutawney Phil predicted that spring will come early this year, so to celebrate we’ve brought together the latest stories in the world of research ethics! In this Research Ethics Roundup installment, learn about burgeoning discussion of the use of placebos in developing countries, recent reports of government agencies funding redundant protocols, and much more!

Ethical controversy in human subjects research: The use of placebo as a control in clinical trials is typically considered unethical if an effective treatment for the condition under study already exists. However, in resource-scarce countries, individuals outside of clinical trials may not have access to those treatments. This blog post from Ruth [...] Read more

28
Jan2013

Today we’d like to introduce you to Christian (Chris) Newcomer, VMD, MS, DACLAM, who is a recent addition to PRIM&R’s Board of Directors.

Dr. Newcomer is the executive director of the Association for Assessment  and Accreditation of Laboratory Animal Care International (AAALAC International) and has participated in AAALAC’s review activities for the past 27 years. Prior to his appointment at AAALAC International, he held academic and leadership positions in laboratory animal medicine at the Massachusetts Institute of [...] Read more